نتایج جستجو برای: ovarian cancer

تعداد نتایج: 956147  

Journal: :International journal of molecular medicine 2014
Yi-Fei Chen Shu-Ying Wang Hong Shen Xiao-Fen Yao Feng-Li Zhang Dongmei Lai

The difficulties faced in the effective treatment of ovarian cancer are multifactorial, but are mainly associated with relapse and drug resistance. Cancer stem-like cells have been reported to be an important contributor to these hindering factors. In this study, we aimed to investigate the anticancer activities of a bioactive fungal metabolite, namely terrein, against the human epithelial ovar...

2013
Ella R. Thompson Simone M. Rowley Sarah Sawyer kConFab Diana M. Eccles Alison H. Trainer Gillian Mitchell Paul A. James Ian G. Campbell

Mutations in RAD51D have been associated with an increased risk of hereditary ovarian cancer and although they have been observed in the context of breast and ovarian cancer families, the association with breast cancer is unclear. The aim of this current study was to validate the reported association of RAD51D with ovarian cancer and assess for an association with breast cancer. We screened for...

Journal: :Clinical journal of oncology nursing 2003
Jennifer O'Rourke Suzanne M Mahon

Ovarian cancer is the leading cause of gynecologic cancer deaths and the fifth leading cause of cancer deaths among American women. Advances in surgery and treatment modalities have slightly improved five-year survival rates, but the prognosis for most women continues to be poor. Rectovaginal examination, ultrasound, and the CA-125 blood test are three modalities currently used to screen for ov...

2017
Satoshi Fukagawa Kohei Miyata Fusanori Yotsumoto Chihiro Kiyoshima Sung Ouk Nam Haruchika Anan Takahiro Katsuda Daisuke Miyahara Masaharu Murata Hiroshi Yagi Kyoko Shirota Shin'ichiro Yasunaga Kiyoko Kato Shingo Miyamoto

Ovarian cancer is the most lethal gynecologic malignancy. Recently, several molecularly targeted anticancer agents have been developed for ovarian cancer; however, its prognosis remains extremely poor. The development of molecularly targeted therapy, as well as companion diagnostics, is required to improve outcomes for patients with ovarian cancer. In this study, to identify microRNAs (miRNAs) ...

Journal: :Carcinogenesis 2001
A B Spurdle P M Webb D M Purdie X Chen A Green G Chenevix-Trench

Epidemiological studies suggest that ovarian cancer is an endocrine-related tumour, and progesterone exposure specifically may decrease the risk of ovarian cancer. To assess whether the progesterone receptor (PR) exon 4 valine to leucine amino acid variant is associated with specific tumour characteristics or with overall risk of ovarian cancer, we examined 551 cases of epithelial ovarian cance...

2014
Jinhua Zhou Yunfei Wang You Wang Xia Yin Yifeng He Lilan Chen Wenwen Wang Ting Liu Wen Di

Cisplatin is commonly used in ovarian cancer chemotherapy, however, chemoresistance to cisplatin remains a great clinical challenge. Oncogenic transcriptional factor FOXM1 has been reported to be overexpressed in ovarian cancer. In this study, we aimed to investigate the potential role of FOXM1 in ovarian cancers with chemoresistance to cisplatin. Our results indicate that FOXM1 is upregulated ...

2018
Biao Zeng Min Zhou Huan Wu Zhengai Xiong

Objectives Ovarian cancer is one of the most lethal malignant tumors in women. Secreted phosphoprotein 1 (SPP1) plays an important role in some cancer types. Therefore, the role of SPP1 in ovarian cancer was determined and the potential mechanism was elucidated. Materials and methods The expression of SPP1 in ovarian cancer was determined by immunohistochemistry in ovarian cancer tissues and ...

Journal: :International journal of advanced research 2021

Ovarian Cancer is a problem battled worldwide and typically diagnosed at an advanced stage due to the lack of effective screening strategies. An method should detect disease earlier diagnosis such that treatment would result in better outcome not inevitable mortality. Diagnosis cancer early (stage 1) could be benefit good strategies because it associated with high 5- year survival rate (95%) as...

2017
Jun Wei Lahong Zhang Jennifer Li Shuguang Zhu Minghui Tai Clifford W. Mason Julia A. Chapman Evelyn A. Reynolds Carl P Weiner Helen H Zhou

BACKGROUND Ovarian cancer is the leading lethal, gynecological malignancy in the United States. No doubt, the continued morbidity and mortality of ovarian cancer reflects a poor understanding of invasive mechanisms. Recent studies reveal that ovarian cancers express aberrant microRNAs (miRNAs or miRs), some of which have oncogenic or tumor suppressor properties. Several studies suggested that m...

Journal: :Human molecular genetics 2009
Honglin Song Susan J Ramus Susanne Krüger Kjaer Richard A DiCioccio Georgia Chenevix-Trench Celeste Leigh Pearce Estrid Hogdall Alice S Whittemore Valerie McGuire Claus Hogdall Jan Blaakaer Anna H Wu David J Van Den Berg Daniel O Stram Usha Menon Aleksandra Gentry-Maharaj Ian J Jacobs Penny M Webb Jonathan Beesley Xiaoqing Chen Mary Anne Rossing Jennifer A Doherty Jenny Chang-Claude Shan Wang-Gohrke Marc T Goodman Galina Lurie Pamela J Thompson Michael E Carney Roberta B Ness Kirsten Moysich Ellen L Goode Robert A Vierkant Julie M Cunningham Stephanie Anderson Joellen M Schildkraut Andrew Berchuck Edwin S Iversen Patricia G Moorman Montserrat Garcia-Closas Stephen Chanock Jolanta Lissowska Louise Brinton Hoda Anton-Culver Argyrios Ziogas Wendy R Brewster Bruce A J Ponder Douglas F Easton Simon A Gayther Paul D P Pharoah

Because both ovarian and breast cancer are hormone-related and are known to have some predisposition genes in common, we evaluated 11 of the most significant hits (six with confirmed associations with breast cancer) from the breast cancer genome-wide association study for association with invasive ovarian cancer. Eleven SNPs were initially genotyped in 2927 invasive ovarian cancer cases and 414...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید